Cover Image

Systemic Immunosuppression for Limbal Allograft and Allogenic Limbal Epithelial Cell Transplantation

Juan Carlos Serna-Ojeda, Sayan Basu, Jayesh Vazirani, Yonathan Garfias, Virender S. Sangwan

Abstract


Bilateral limbal stem cell deficiency (LSCD) treatment requires the need to obtain allogenic limbal tissue for transplantation. Outcomes of different surgical techniques depend on multiple factors, including the underlying etiology, ocular surface, eyelid status and used surgical intervention. Some of the management options for bilateral LSCD include cadaveric, living related or living non-related conjunctival limbal allograft (CLAL), keratolimbal allograft (KLAL), allogenic cultured limbal epithelial transplantation (CLET) and allogenic simple limbal epithelial transplantation (SLET). Systemic immunosuppressive therapy plays a pivotal role in survival of transplanted tissue. The present review focuses on different systemic immunosuppression protocols for limbal allograft and allogenic limbal epithelial cell transplantation, with specific emphasis on different surgical techniques and their outcomes. We included all reports with details of different systemic immunosuppression protocols for limbal allograft and allogenic limbal epithelial cell transplantation. Oral cyclosporine A at different doses is the most commonly used immunosuppressive agent in limbal allograft and allogenic limbal epithelial cell transplantation. However, different studies using oral mycophenolate mofetil and tacrolimus also reported good results. In conclusion, systemic immunosuppression protocols for limbal allograft and allogenic limbal epithelial cell transplantation are not standardized. Further studies regarding different surgical techniques should assess outcomes and adverse effects of such protocols.


References


Dua HS, Miri A, Said DG. Contemporary limbal stem cell transplantation - a review. Clin Exp Ophthalmol. 2010;38(2):104-17. doi: 10.1111/j.1442-9071.2010.02229.x pmid: 20398102

Vazirani J, Nair D, Shanbhag S, Wurity S, Ranjan A, Sangwan V. Limbal Stem Cell Deficiency-Demography and Underlying Causes. Am J Ophthalmol. 2018;188:99-103. doi: 10.1016/j.ajo.2018.01.020 pmid: 29378178

Liang L, Sheha H, Li J, Tseng SC. Limbal stem cell transplantation: new progresses and challenges. Eye (Lond). 2009;23(10):1946-53. doi: 10.1038/eye.2008.379 pmid: 19098704

Ramachandran C, Basu S, Sangwan VS, Balasubramanian D. Concise review: the coming of age of stem cell treatment for corneal surface damage. Stem Cells Transl Med. 2014; 3(10):1160-8. doi: 10.5966/sctm.2014-0064 pmid: 25205842

Daya SM, Chan CC, Holland EJ, Members of The Cornea Society Ocular Surface Procedures Nomenclature C. Cornea Society nomenclature for ocular surface rehabilitative procedures. Cornea. 2011;30(10):1115-9. doi: 10.1097/ ICO.0b013e318207f135 pmid: 21642849

Nakamura T, Inatomi T, Sotozono C, Koizumi N, Kinoshita S. Ocular surface reconstruction using stem cell and tissue engineering. Prog Retin Eye Res. 2016;51:187-207. doi: 10. 1016/j.preteyeres.2015.07.003 pmid: 26187034

Haagdorens M, Van Acker SI, Van Gerwen V, Ni Dhubhghaill S, Koppen C, Tassignon MJ, et al. Limbal Stem Cell Deficiency: Current Treatment Options and Emerging Therapies. Stem Cells Int. 2016;2016:9798374. doi: 10.1155/2016/9798374 pmid: 26788074

Cauchi PA, Ang GS, Azuara-Blanco A, Burr JM. A systematic literature review of surgical interventions for limbal stem cell deficiency in humans. Am J Ophthalmol. 2008;146(2):251-9. doi: 10.1016/j.ajo.2008.03.018 pmid: 18486098

Espana EM, Di Pascuale M, Grueterich M, Solomon A, Tseng SC. Keratolimbal allograft in corneal reconstruction. Eye (Lond). 2004;18(4):406-17. doi: 10.1038/sj.eye.6700670 pmid: 15069439

Holland EJ, Mogilishetty G, Skeens HM, Hair DB, Neff KD, Biber JM, et al. Systemic immunosuppression in ocular surface stem cell transplantation: results of a 10-year experience. Cornea. 2012;31(6):655-61. doi: 10.1097/ICO. 0b013e31823f8b0c pmid: 22333664

Atallah MR, Palioura S, Perez VL, Amescua G. Limbal stem cell transplantation: current perspectives. Clin Ophthalmol. 2016;10:593-602. doi: 10.2147/OPTH.S83676 pmid: 27099468

Kwitko S, Marinho D, Barcaro S, Bocaccio F, Rymer S, Fernandes S, et al. Allograft conjunctival transplantation for bilateral ocular surface disorders. Ophthalmology. 1995; 102(7):1020-5. doi: 10.1016/s0161-6420(95)30918-9 pmid: 9121746

Scocco C, Kwitko S, Rymer S, Marinho D, Bocaccio F, Lindenmeyer R. HLA-matched living-related conjunctival limbal allograft for bilateral ocular surface disorders: long-term results. Arq Bras Oftalmol. 2008;71(6):781-7. doi: 10. 1590/s0004-27492008000600003 pmid: 19169506

Daya SM, Ilari FACSL. Living related conjunctival limbal allograft for the treatment of stem cell deficiency. Ophthalmology. 2001;108(1):126-33. doi: 10.1016/s0161-6420(00)00475-9

Gomes JA, Santos MS, Ventura AS, Donato WB, Cunha MC, Hofling-Lima AL. Amniotic membrane with living related corneal limbal/conjunctival allograft for ocular surface reconstruction in Stevens-Johnson syndrome. Arch Ophthalmol. 2003;121(10):1369-74. doi: 10.1001/archopht. 121.10.1369 pmid: 14557171

Santos MS, Gomes JA, Hofling-Lima AL, Rizzo LV, Romano AC, Belfort R, Jr. Survival analysis of conjunctival limbal grafts and amniotic membrane transplantation in eyes with total limbal stem cell deficiency. Am J Ophthalmol. 2005; 140(2):223-30. doi: 10.1016/j.ajo.2005.03.022 pmid: 16023069

Javadi MA, Baradaran-Rafii A. Living-related conjunctival-limbal allograft for chronic or delayed-onset mustard gas keratopathy. Cornea. 2009;28(1):51-7. doi: 10.1097/ICO. 0b013e3181852673 pmid: 19092406

Barreiro TP, Santos MS, Vieira AC, de Nadai Barros J, Hazarbassanov RM, Gomes JA. Comparative study of conjunctival limbal transplantation not associated with the use of amniotic membrane transplantation for treatment of total limbal deficiency secondary to chemical injury. Cornea. 2014;33(7):716-20. doi: 10.1097/ICO.0000000000000139 pmid: 24831198

Tsubota K, Shimmura S, Shinozaki N, Holland EJ, Shimazaki J. Clinical application of living-related conjunctival-limbal allograft. Am J Ophthalmol. 2002;133(1):134-5. doi: 10. 1016/s0002-9394(01)01208-9 pmid: 11755849

Sangwan VS, Matalia HP, Vemuganti GK, Ifthekar G, Fatima A, Singh S, et al. Early results of penetrating keratoplasty after cultivated limbal epithelium transplantation. Arch Ophthalmol. 2005;123(3):334-40. doi: 10.1001/archopht. 123.3.334 pmid: 15767475

Welder JD, Pandya HK, Nassiri N, Djalilian AR. Conjunctival limbal autograft and allograft transplantation using fibrin glue. Ophthalmic Surg Lasers Imaging. 2012;43(4):323-7. doi: 10.3928/15428877-20120618-04 pmid: 22788584

Rao SK, Rajagopal R, Sitalakshmi G, Padmanabhan P. Limbal allografting from related live donors for corneal surface reconstruction. Ophthalmology. 1999;106(4):822-8. doi: 10. 1016/S0161-6420(99)90173-2 pmid: 10201609

Shimazaki J, Shimmura S, Tsubota K. Donor source affects the outcome of ocular surface reconstruction in chemical or thermal burns of the cornea. Ophthalmology. 2004; 111(1):38-44. doi: 10.1016/j.ophtha.2003.02.003 pmid: 14711712

Daya SM, Bell RW, Habib NE, Powell-Richards A, Dua HS. Clinical and pathologic findings in human keratolimbal allograft rejection. Cornea. 2000;19(4):443-50. doi: 10.1097/ 00003226-200007000-00007 pmid: 10928754

Tsai RJ, Tseng SC. Human allograft limbal transplantation for corneal surface reconstruction. Cornea. 1994;13(5):389-400. doi: 10.1097/00003226-199409000-00003 pmid: 7995060

Tan DT, Ficker LA, Buckley RJ. Limbal Transplantation. Ophthalmology. 1996;103(1):29-36. doi: 10.1016/s0161-6420 (96)30737-9

Holland EJ. Epithelial transplantation for the management of severe ocular surface disease. Transactions of the American Ophthalmological Society. 1996;94:677.

Tsubota K, Toda I, Saito H, Shinozaki N, Shimazaki J. Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology. 1995;102(10):1486-96. doi: 10.1016/s0161-6420(95)30841-x pmid: 9097796

Tsubota K, Satake Y, Kaido M, Shinozaki N, Shimmura S, Bissen-Miyajima H, et al. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med. 1999;340(22):1697-703. doi: 10.1056/ NEJM199906033402201 pmid: 10352161

Parihar JKS, Parihar AS, Jain VK, Kaushik J, Nath P. Allogenic cultivated limbal stem cell transplantation versus cadaveric keratolimbal allograft in ocular surface disorder: 1-year outcome. Int Ophthalmol. 2017;37(6):1323-31. doi: 10. 1007/s10792-016-0415-0 pmid: 28025793

Ilari L, Daya SM. Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. Ophthalmology. 2002;109(7):1278-84. doi: 10. 1016/s0161-6420(02)01081-3 pmid: 12093650

Solomon A, Ellies P, Anderson DF, Touhami A, Grueterich M, Espana EM, et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology. 2002; 109(6):1159-66. doi: 10.1016/s0161-6420(02)00960-0

Maruyama-Hosoi F, Shimazaki J, Shimmura S, Tsubota K. Changes observed in keratolimbal allograft. Cornea. 2006; 25(4):377-82. doi: 10.1097/01.ico.0000176608.65708.27 pmid: 16670472

Shimazaki J, Shimmura S, Fujishima H, Tsubota K. Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. Ophthalmology. 2000; 107(8):1518-23. doi: 10.1016/s0161-6420(00)00214-1 pmid: 10919901

Shi W, Gao H, Wang T, Xie L. Combined penetrating keratoplasty and keratolimbal allograft transplantation in comparison with corneoscleral transplantation in the treatment of severe eye burns. Clin Exp Ophthalmol. 2008; 36(6):501-7. doi: 10.1111/j.1442-9071.2008.01802.x pmid: 18954310

Shimazaki J, Maruyama F, Shimmura S, Fujishima H, Tsubota K. Immunologic rejection of the central graft after limbal allograft transplantation combined with penetrating keratoplasty. Cornea. 2001;20(2):149-52. doi: 10.1097/ 00003226-200103000-00006 pmid: 11248817

Dua HS, Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol. 1999; 83(4):414-9. doi: 10.1136/bjo.83.4.414 pmid: 10434862

Henderson TR, Coster DJ, Williams KA. The long term outcome of limbal allografts: the search for surviving cells. Br J Ophthalmol. 2001;85(5):604-9. doi: 10.1136/bjo.85.5.604 pmid: 11316725

Holland EJ, Djalilian AR, Schwartz GS. Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology. 2003; 110(1):125-30. doi: 10.1016/s0161-6420(02)01451-3 pmid: 12511357

Shen C, Chan CC, Holland EJ. Limbal Stem Cell Transplantation for Soft Contact Lens Wear-Related Limbal Stem Cell Deficiency. Am J Ophthalmol. 2015;160(6):1142-9 e1. doi: 10.1016/j.ajo.2015.07.038 pmid: 26299533

Movahedan A, Genereux BM, Darvish-Zargar M, Shah KJ, Holland EJ. Long-term management of severe ocular surface injury due to methamphetamine production accidents. Cornea. 2015;34(4):433-7. doi: 10.1097/ICO.00000000 00000364 pmid: 25642642

Ang AY, Chan CC, Biber JM, Holland EJ. Ocular surface stem cell transplantation rejection: incidence, characteristics, and outcomes. Cornea. 2013;32(3):229-36. doi: 10.1097/ICO. 0b013e318255eac4 pmid: 22668584

Liang L, Sheha H, Tseng SC. Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits. Arch Ophthalmol. 2009; 127(11):1428-34. doi: 10.1001/archophthalmol.2009.263 pmid: 19901207

Jafarinasab MR, Feizi S, Javadi MA, Karimian F, Soroush MR. Lamellar keratoplasty and keratolimbal allograft for mustard gas keratitis. Am J Ophthalmol. 2011;152(6):925-32 e2. doi: 10.1016/j.ajo.2011.05.018 pmid: 21871601

Javadi MA, Jafarinasab MR, Feizi S, Karimian F, Negahban K. Management of mustard gas-induced limbal stem cell deficiency and keratitis. Ophthalmology. 2011;118(7):1272-81. doi: 10.1016/j.ophtha.2010.11.012 pmid: 21397949

Biber JM, Skeens HM, Neff KD, Holland EJ. The cincinnati procedure: technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure. Cornea. 2011; 30(7):765-71. doi: 10.1097/ICO.0b013e318201467c pmid: 21325942

Chan CC, Biber JM, Holland EJ. The modified Cincinnati procedure: combined conjunctival limbal autografts and keratolimbal allografts for severe unilateral ocular surface failure. Cornea. 2012;31(11):1264-72. doi: 10.1097/ICO. 0b013e31823f8e95 pmid: 22406944

Han ES, Wee WR, Lee JH, Kim MK. Long-term outcome and prognostic factor analysis for keratolimbal allografts. Graefes Arch Clin Exp Ophthalmol. 2011;249(11):1697-704. doi: 10.1007/s00417-011-1760-3 pmid: 21837442

Squissato V, Schiff J, Chan CC. Intravenous immunoglobulin for antibody-mediated keratolimbal allograft rejection. BMJ Case Rep. 2015;2015. doi: 10.1136/bcr-2015-210733 pmid: 26113596

Krakauer M, Welder JD, Pandya HK, Nassiri N, Djalilian AR. Adverse effects of systemic immunosuppression in keratolimbal allograft. J Ophthalmol. 2012;2012:576712. doi: 10.1155/2012/576712 pmid: 22523651

Baradaran-Rafii A, Eslani M, Djalillian AR. Complications of keratolimbal allograft surgery. Cornea. 2013;32(5):561-6. doi: 10.1097/ICO.0b013e31826215eb pmid: 23073489

Eslani M, Haq Z, Movahedan A, Moss A, Baradaran-Rafii A, Mogilishetty G, et al. Late Acute Rejection After Allograft Limbal Stem Cell Transplantation: Evidence for Long-Term Donor Survival. Cornea. 2017;36(1):26-31. doi: 10.1097/ICO.0000000000000970 pmid: 27467047

Kinoshita S, Koizumi N, Nakamura T. Transplantable cultivated mucosal epithelial sheet for ocular surface reconstruction. Exp Eye Res. 2004;78(3):483-91. doi: 10.1016/j.exer.2003.09.004 pmid: 15106927

Satake Y, Yamaguchi T, Hirayama M, Higa K, Shimazaki-Den S, Dogru M, et al. Ocular surface reconstruction by cultivated epithelial sheet transplantation. Cornea. 2014;33 Suppl 11: S42-6. doi: 10.1097/ICO.0000000000000242 pmid: 25289723

Zhao Y, Ma L. Systematic review and meta-analysis on transplantation of ex vivo cultivated limbal epithelial stem cell on amniotic membrane in limbal stem cell deficiency. Cornea. 2015;34(5):592-600. doi: 10.1097/ICO.000000000 0000398 pmid: 25789694

Shortt AJ, Secker GA, Notara MD, Limb GA, Khaw PT, Tuft SJ, et al. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol. 2007;52(5):483-502. doi: 10.1016/j. survophthal.2007.06.013 pmid: 17719371

Schwab IR. Cultured corneal epithelia for ocular surface disease. Trans Am Ophthalmol Soc. 1999;97:891-986. pmid: 10703147

Schwab IR, Reyes M, Isseroff RR. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea. 2000;19(4):421-6. doi: 10.1097/ 00003226-200007000-00003 pmid: 10928750

Daya SM, Watson A, Sharpe JR, Giledi O, Rowe A, Martin R, et al. Outcomes and DNA analysis of ex vivo expanded stem cell allograft for ocular surface reconstruction. Ophthalmology. 2005;112(3):470-7. doi: 10.1016/j.ophtha. 2004.09.023 pmid: 15745776

Shimazaki J, Aiba M, Goto E, Kato N, Shimmura S, Tsubota K. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology. 2002;109(7):1285-90. doi: 10.1016/s0161-6420(02)01089-8 pmid: 12093651

Shimazaki J, Higa K, Morito F, Dogru M, Kawakita T, Satake Y, et al. Factors influencing outcomes in cultivated limbal epithelial transplantation for chronic cicatricial ocular surface disorders. Am J Ophthalmol. 2007;143(6):945-53. doi: 10.1016/j.ajo.2007.03.005 pmid: 17459317

Kawashima M, Kawakita T, Satake Y, Higa K, Shimazaki J. Phenotypic study after cultivated limbal epithelial transplantation for limbal stem cell deficiency. Arch Ophthalmol. 2007;125(10):1337-44. doi: 10.1001/archopht. 125.10.1337 pmid: 17923540

Satake Y, Dogru M, Yamaguchi T, Tomida D, Hirayama M, Shimazaki J. Immunological rejection following allogeneic cultivated limbal epithelial transplantation. JAMA Ophthalmol. 2013;131(7):920-2. doi: 10.1001/ jamaophthalmol.2013.15 pmid: 23559125

Prabhasawat P, Ekpo P, Uiprasertkul M, Chotikavanich S, Tesavibul N. Efficacy of cultivated corneal epithelial stem cells for ocular surface reconstruction. Clin Ophthalmol. 2012;6:1483-92. doi: 10.2147/OPTH.S33951 pmid: 23055668

Shortt AJ, Secker GA, Rajan MS, Meligonis G, Dart JK, Tuft SJ, et al. Ex vivo expansion and transplantation of limbal epithelial stem cells. Ophthalmology. 2008;115(11):1989-97. doi: 10.1016/j.ophtha.2008.04.039 pmid: 18554721

Zakaria N, Possemiers T, Dhubhghaill SN, Leysen I, Rozema J, Koppen C, et al. Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation. J Transl Med. 2014;12:58. doi: 10. 1186/1479-5876-12-58 pmid: 24589151

Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders11The authors have no financial interest in this work. Ophthalmology. 2001;108(9):1569-74. doi: 10.1016/s0161-6420(01)00694-7

Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S. Cultivated corneal epithelial transplantation for ocular surface reconstruction in acute phase of Stevens-Johnson syndrome. Arch Ophthalmol. 2001;119(2):298-300. pmid: 11176998

Nakamura T, Inatomi T, Sotozono C, Ang LP, Koizumi N, Yokoi N, et al. Transplantation of autologous serum-derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease. Ophthalmology. 2006; 113(10):1765-72. doi: 10.1016/j.ophtha.2006.04.030 pmid: 16905193

Nakamura T, Sotozono C, Bentley AJ, Mano S, Inatomi T, Koizumi N, et al. Long-term phenotypic study after allogeneic cultivated corneal limbal epithelial transplantation for severe ocular surface diseases. Ophthalmology. 2010;117(12):2247-54 e1. doi: 10.1016/j.ophtha.2010.04. 003 pmid: 20673588

Pauklin M, Fuchsluger TA, Westekemper H, Steuhl KP, Meller D. Midterm results of cultivated autologous and allogeneic limbal epithelial transplantation in limbal stem cell deficiency. Dev Ophthalmol. 2010;45:57-70. doi: 10.1159/ 000315020 pmid: 20502027

Sangwan VS, Basu S, MacNeil S, Balasubramanian D. Simple limbal epithelial transplantation (SLET): a novel surgical technique for the treatment of unilateral limbal stem cell deficiency. Br J Ophthalmol. 2012;96(7):931-4. doi: 10.1136/ bjophthalmol-2011-301164 pmid: 22328817

Basu S, Sureka SP, Shanbhag SS, Kethiri AR, Singh V, Sangwan VS. Simple Limbal Epithelial Transplantation: Long-Term Clinical Outcomes in 125 Cases of Unilateral Chronic Ocular Surface Burns. Ophthalmology. 2016;123(5):1000-10. doi: 10.1016/j.ophtha.2015.12.042 pmid: 26896125

Bhalekar S, Basu S, Sangwan VS. Successful management of immunological rejection following allogeneic simple limbal epithelial transplantation (SLET) for bilateral ocular burns. BMJ Case Rep. 2013;2013. doi: 10.1136/bcr-2013-009051 pmid: 23505089

Iyer G, Srinivasan B, Agarwal S, Tarigopula A. Outcome of allo simple limbal epithelial transplantation (alloSLET) in the early stage of ocular chemical injury. Br J Ophthalmol. 2017; 101(6):828-33. doi: 10.1136/bjophthalmol-2016-309045 pmid: 28407620


Full Text: Full Text PDF-Epub: Nov 30, 2019

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.